I E van der Horst-Bruinsma Selected Research

I E van der Horst-Bruinsma Research Topics

Disease

25	Ankylosing Spondylitis 11/2022 - 04/2000
12	Rheumatoid Arthritis 10/2015 - 02/2001
9	Inflammation (Inflammations) 02/2021 - 01/2003
6	Arthritis (Polyarthritis) 03/2010 - 02/2001
3	Necrosis 11/2022 - 03/2009
2	Joint Diseases (Joint Disease) 02/2021 - 01/2020
2	Psoriatic Arthritis 01/2020 - 01/2020
2	Arthralgia (Joint Pain) 03/2010 - 09/2008
2	Anterior Uveitis 07/2009 - 04/2000
2	Crohn Disease (Crohn's Disease) 01/2003 - 12/2002
1	Disease Progression 05/2022
1	Back Pain (Backache) 05/2022
1	Non-Radiographic Axial Spondyloarthritis 05/2022
1	Insulin Resistance 02/2021
1	Axial Spondyloarthritis 01/2020
1	Left Ventricular Dysfunction 01/2018
1	Uveitis 11/2015
1	Liver Diseases (Liver Disease) 12/2012
1	Hypersensitivity (Allergy) 07/2011
1	Osteoporosis 04/2011
1	Metabolic Bone Diseases (Osteopenia) 04/2011
1	Peptic Ulcer (Peptic Ulcers) 07/2009
1	Scleritis (Episcleritis) 07/2009
1	Pericarditis 07/2009
1	Colitis 07/2009
1	Fibrosis (Cirrhosis) 07/2009
1	Acute-Phase Reaction 04/2006
1	Ulcerative Colitis 12/2002
1	Spondylarthropathies 11/2002
1	Rheumatic Diseases (Rheumatism) 11/2002
1	Infections 04/2000

Drug/Important Bio-Agent (IBA)

8	Etanercept (Enbrel)FDA Link 05/2022 - 11/2006
8	AntibodiesIBA 03/2010 - 04/2000
5	C-Reactive ProteinIBA 03/2018 - 08/2002
5	Anti-Citrullinated Protein AntibodiesIBA 03/2010 - 03/2005
4	Adalimumab (Humira)FDA Link 03/2018 - 08/2009
4	Immunoglobulin M (IgM)IBA 03/2010 - 08/2002
4	EpitopesIBA 03/2010 - 02/2001
3	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2022 - 04/2011
3	Infliximab (Remicade)FDA Link 01/2016 - 01/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2012 - 03/2009
3	HDL CholesterolIBA 05/2009 - 11/2006
3	LipidsIBA 05/2009 - 11/2006
3	AutoantibodiesIBA 04/2006 - 03/2005
3	DNA (Deoxyribonucleic Acid)IBA 04/2005 - 04/2000
2	Pharmaceutical PreparationsIBA 11/2022 - 03/2018
2	Rheumatoid FactorIBA 03/2010 - 04/2006
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 07/2009 - 09/2003
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 05/2009 - 02/2007
2	cyclic citrullinated peptideIBA 09/2008 - 08/2005
2	Triglycerides (Triacylglycerol)IBA 02/2007 - 11/2006
2	CholesterolIBA 02/2007 - 11/2006
2	Leflunomide (Arava)FDA LinkGeneric 11/2006 - 12/2005
2	Peptides (Polypeptides)IBA 04/2006 - 03/2005
1	Biological ProductsIBA 05/2022
1	amsonic acid (DAS)IBA 01/2020
1	Tumor Necrosis Factor InhibitorsIBA 01/2020
1	Alkaline PhosphataseIBA 12/2018
1	golimumab FDA Link 01/2018
1	EnzymesIBA 12/2012
1	Interleukin-10 (Interleukin 10)IBA 08/2009
1	HDL LipoproteinsIBA 05/2009
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 05/2009
1	Apolipoproteins B (ApoB)IBA 02/2007
1	ApolipoproteinsIBA 02/2007
1	Lipoprotein(a)IBA 02/2007
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2006
1	Secretory Phospholipases A2IBA 04/2006
1	Fibrinogen (Factor I)FDA Link 08/2005
1	Transforming Growth Factor beta (TGF-beta)IBA 04/2005
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 04/2005
1	CytokinesIBA 04/2005
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2005
1	Toll-Like Receptor 4IBA 02/2005
1	NF-kappa B (NF-kB)IBA 01/2003
1	NucleotidesIBA 01/2003
1	Proteins (Proteins, Gene)FDA Link 01/2003
1	Interleukin-1beta (Interleukin 1 beta)IBA 12/2002
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 12/2002
1	Antirheumatic Agents (DMARD)IBA 11/2002
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 11/2002
1	HLA-DQ Antigens (HLA-DQ)IBA 02/2001
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2001

Therapy/Procedure

4	Therapeutics 02/2021 - 05/2006
1	Drug Tapering 01/2016
1	Lasers (Laser) 05/2009
1	Intramuscular Injections 03/2005